Biolase Inc Stock Forecast, Predictions & Price Target

Analyst price target for BIOL

Based on 2 analysts offering 12 month price targets for Biolase Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell BIOL stock?

Based on 2 analysts offering ratings for Biolase Inc.
Strong Buy
0 analysts 0%
2 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BIOL stock forecasts and price targets.

BIOL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color

1 of 1

BIOL vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus

Biolase Stock Forecast FAQ

Is Biolase Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BIOL) stock is to Buy BIOL stock.

Out of 2 analysts, 0 (0%) are recommending BIOL as a Strong Buy, 2 (100%) are recommending BIOL as a Buy, 0 (0%) are recommending BIOL as a Hold, 0 (0%) are recommending BIOL as a Sell, and 0 (0%) are recommending BIOL as a Strong Sell.

If you're new to stock investing, here's how to buy Biolase stock.

What is BIOL's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BIOL price target, the average BIOL price target is $2.20, with the highest BIOL stock price forecast at $4.00 and the lowest BIOL stock price forecast at $0.40.

On average, Wall Street analysts predict that Biolase's share price could reach $2.20 by May 14, 2025. The average Biolase stock price prediction forecasts a potential upside of 1,283.65% from the current BIOL share price of $0.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.